1.
Palani P, Sharmila V, Arun Babu T, K. K. G. Efficacy of cabergoline in the prevention of severe ovarian hyperstimulation syndrome in high-risk women undergoing assisted reproductive technology treatment. Int J Reprod Contracept Obstet Gynecol [Internet]. 2022 Jul. 27 [cited 2025 Dec. 7];11(8):2147-51. Available from: https://www.ijrcog.org/index.php/ijrcog/article/view/11837